ArticleCureus2025
Hypopituitarism and Other Endocrinopathies as a Consequence of Septo-Optic Dysplasia.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Septo-optic dysplasia (SOD) is a rare disorder that affects early brain development. It is characterized and diagnosed by the presence of at least two out of the following: optic nerve hypoplasia, agenesis of the septum pellucidum, and pituitary hypoplasia. Currently, the cause of the disease is largely thought to be sporadic and involves both genetic and environmental factors. We report the case of a 29-year-old female patient who was diagnosed with SOD after years of diagnostic investigation as well as the emergence of multiple endocrine pathologies related to her SOD. The patient is currently being treated with a variety of hormones to manage her endocrinopathies and is predicted to have a favorable prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.